Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.2 EUR
−12.04 M EUR
1.80 B EUR
14.69 M
About REDCARE PHARMACY N.V.
Sector
Industry
CEO
Olaf Heinrich
Website
Headquarters
Sevenum
Founded
2021
ISIN
NL0012044747
Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. It operates under the DACH and International segments. The DACH segment includes medications and pharmacy-related BPC products sold to customers in Germany, Austria, and Switzerland. The International segment focuses on Belgium, the Netherlands, France, and Italy. The company was founded by Frank Köhler, Stephan Weber, and Marc Fischer in January 2001 and is headquartered in Sevenum, the Netherlands.
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange REDCARE PHARMA stocks are traded under the ticker 1RDC.
1RDC stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in REDCARE PHARMA price.
We've gathered analysts' opinions on REDCARE PHARMA future price: according to them, 1RDC price has a max estimate of 202.00 EUR and a min estimate of 85.00 EUR. Watch 1RDC chart and read a more detailed REDCARE PHARMA stock forecast: see what analysts think of REDCARE PHARMA and suggest that you do with its stocks.
1RDC stock is 0.00% volatile and has beta coefficient of 0.99. Track REDCARE PHARMA stock price on the chart and check out the list of the most volatile stocks — is REDCARE PHARMA there?
Today REDCARE PHARMA has the market capitalization of 2.43 B, it has increased by 5.47% over the last week.
Yes, you can track REDCARE PHARMA financials in yearly and quarterly reports right on TradingView.
REDCARE PHARMA is going to release the next earnings report on Mar 11, 2025. Keep track of upcoming events with our Earnings Calendar.
1RDC earnings for the last quarter are −0.41 EUR per share, whereas the estimation was −0.66 EUR resulting in a 37.23% surprise. The estimated earnings for the next quarter are −0.92 EUR per share. See more details about REDCARE PHARMA earnings.
REDCARE PHARMA revenue for the last quarter amounts to 574.55 M EUR, despite the estimated figure of 574.91 M EUR. In the next quarter, revenue is expected to reach 674.77 M EUR.
1RDC net income for the last quarter is −6.91 M EUR, while the quarter before that showed −4.27 M EUR of net income which accounts for −62.03% change. Track more REDCARE PHARMA financial stats to get the full picture.
No, 1RDC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 10, 2025, the company has 2.08 K employees. See our rating of the largest employees — is REDCARE PHARMA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REDCARE PHARMA EBITDA is 29.62 M EUR, and current EBITDA margin is 2.25%. See more stats in REDCARE PHARMA financial statements.
Like other stocks, 1RDC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REDCARE PHARMA stock right from TradingView charts — choose your broker and connect to your account.